Array Biopharma — 328 Patents, Ranked #2,388

Patents per Year

Showing 51–100 of 335 inventors

Rank	Name	Patents
#48	Jun Liang	14
#48	Peter J. Stengel	14
#53	Fredrik P. Marmsater	13
#53	Guy P.A. Vigers	13
#53	Jeremy Hans	13
#53	Kevin W. Hunt	13
#53	Mark Laurence Boys	13
#53	Robert D. Groneberg	13
#53	Stephen T. Schlachter	13
#53	Weidong Liu	13
#61	Megan L. McKenney	12
#62	Brian Safina	11
#62	David A. Mareska	11
#62	Lily Huang	11
#62	Michael Lyon	11
#62	Shane M. Walls	11
#67	Ajay Singh	10
#67	Alexandre Joseph Buckmelter	10
#67	Bin Wang	10
#67	Ganghyeok Kim	10
#67	Huifen Chen	10
#67	Jacob Bradley Schwarz	10
#67	Sagar Shakya	10
#67	Sean Aronow	10
#67	Yvan Le Huerou	10
#76	Allen A. Thomas	9
#76	Christine Chabot	9
#76	Christopher P. Corrette	9
#76	Daniel J. Watson	9
#76	Matthew Arnold Marx	9
#76	Macedonio J. Mejia	9
#76	Paul Nichols	9
#83	Anna L. Banka	8
#83	Charles Todd Eary	8
#83	Darren Harvey	8
#83	Daniel Poon	8
#83	Ginelle A. Ramann	8
#83	Jonas Grina	8
#83	John Tellew	8
#83	Rustam Ferdinand Garrey	8
#83	Shenlin Huang	8
#83	Xianming Jin	8
#83	Xing Wang	8
#83	Yongqin Wan	8
#83	Yongping Xie	8
#83	Zuosheng Liu	8
#97	Bruno P. Hache	7
#97	Christoph Max Krell	7
#97	Daniel Andreas Niederer	7
#97	Daniel Zimmermann	7

Patent	Est. Value	Year
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain	$182M	2019
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors	$182M	2019
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors	$55M	2019
Macrocyclic compounds as TRK kinase inhibitors	$53M	2018
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases	$53M	2019